Posted on by Mike Yeomans
The University of Pittsburgh announced that Pitt innovators were issued 10 U.S. patents in April 2021. Muti-drug resistant bacteria are an urgent healthcare threat. Pitt innovator Nicolas Sluis-Cremer and colleagues …
Posted on by Mike Yeomans
If ever there was a time to celebrate the power of innovation, it is in the wake of the wave of innovation unleashed by the SARS CoV-2 pandemic. At the …
Posted on by Mike Yeomans
The University of Pittsburgh announced that Pitt innovators were issued 12 U.S. patents in March 2021. Approximately 10 million people worldwide suffer from corneal blindness due to corneal scarring. The …
Posted on by Mike Yeomans
The University of Pittsburgh announced that Pitt innovators were issued nine U.S. patents in February 2021. Zika flavivirus has been declared a global emergency by the World Health Organization due …
Posted on by Mike Yeomans
Pancreatic cancer. Just hearing those words produces a chilling feeling of dread. It is among the most deadly and difficult to treat cancers, in part because it forms dense tumors …
Posted on by Mike Yeomans
The Henry L. Hillman Foundation has committed $25 million to the University of Pittsburgh to support research into vision restoration and care, in addition to supporting the region’s burgeoning life …
Posted on by Mike Yeomans
University of Pittsburgh Faculty Elected Senior Members of the National Academy of Inventors The National Academy of Inventors (NAI) has selected three University of Pittsburgh professors among 61 academic inventors …
Posted on by Mike Yeomans
The University of Pittsburgh announced that Pitt innovators were issued 13 U.S. patents in January 2021. Kevin Peng Chen, professor of computer and electrical engineering, and colleagues have developed a …
Posted on by Mike Yeomans
Stephen Popielarski, PhD, had been a mentor for Phase I Ventures, a Philadelphia-based startup accelerator that matches university startups with experienced entrepreneurs, when he was asked to review a batch …
Posted on by Mike Yeomans
The University of Pittsburgh announced that Pitt innovators were issued 16 U.S. patents in December 2020. Using herpes simplex virus (HSV) gene vectors, Pitt researchers from the lab of Joseph …
Posted on by Mike Yeomans
BlueSphere licensed technology from the lab of Mark Shlomchik, chair of the Department of Immunology at the Pitt Medical School, aimed at developing personalized T-cell therapies for cancer and other …
Posted on by Mike Yeomans
Forge Biologics, A Columbus, Ohio-based gene therapy manufacturing and development company, is set to begin Phas I and 2 clinical trials of a gene therapy to treat Krabbe …